Use of JC virus antibody index to stratify risk of progressive multifocal leukoencephalopathy in natalizumab-treated patients with multiple sclerosis

被引：0
|
作者：
Plavina, T. [1 ]
Subramanyam, M. [1 ]
Bloomgren, G. [1 ]
Richman, S. [1 ]
Pace, A. [1 ]
Lee, S. [1 ]
Schlain, B. [1 ]
Campagnolo, D. [1 ]
Ticho, B. [1 ]
机构：
[1] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O228
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Contribution of natalizumab treatment duration, prior immunosuppressant use, and anti-JC virus antibody status to the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients
    Bloomgren, G.
    Richman, S.
    Hotermans, C.
    Subramanyam, M.
    Goelz, S.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Scanlon, J.
    Sandrock, A.
    Bozic, C.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S451 - S452
  • [2] CONTRIBUTION OF NATALIZUMAB EXPOSURE, PRIOR IMMUNOSUPPRESSANT (IS) USE, AND JC VIRUS (JCV) INFECTION TO PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) RISK IN NATALIZUMAB-TREATED MULTIPLE SCLEROSIS (MS) PATIENTS
    Bloomgren, G.
    Richman, S.
    Goelz, S.
    Hotermans, C.
    Hyde, R.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Subramanyam, M.
    Sandrock, A. W.
    Bozic, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 60 - 60
  • [3] Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy
    Serana, Federico
    Chiarini, Marco
    Sottini, Alessandra
    Bertoli, Diego
    Giustini, Viviana
    Tessitore, Marion Vaglio
    Caimi, Luigi
    Capra, Ruggero
    Imberti, Luisa
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 277 (1-2) : 6 - 12
  • [4] Updated analysis of progressive multifocal leukoencephalopathy risk factors in natalizumab-treated multiple sclerosis patients
    Bloomgren, G.
    Richman, S.
    Arnold, R.
    Subramanyam, M.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Scanlon, J.
    Sandrock, A.
    Bozic, C.
    JOURNAL OF NEUROLOGY, 2012, 259 : S37 - S37
  • [5] JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab
    Ryschkewitsch, Caroline F.
    Jensen, Peter N.
    Monaco, Maria Chiara
    Major, Eugene O.
    ANNALS OF NEUROLOGY, 2010, 68 (03) : 384 - 391
  • [6] Matrix Metalloproteinase 9 Is Decreased in Natalizumab-Treated Multiple Sclerosis Patients at Risk for Progressive Multifocal Leukoencephalopathy
    Fissolo, Nicolas
    Pignolet, Beatrice
    Matute-Blanch, Clara
    Trivino, Juan Carlos
    Miro, Berta
    Mota, Miriam
    Perez-Hoyos, Santiago
    Sanchez, Alex
    Vermersch, Patrick
    Ruet, Aurelie
    Vermersch, Patrick
    Ruet, Aurelie
    de Seze, Jerome
    Labauge, Pierre
    Vukusic, Sandra
    Papeix, Caroline
    Almoyna, Laurent
    Tourbah, Ayman
    Clavelou, Pierre
    Moreau, Thibault
    Pelletier, Jean
    Lebrun-Frenay, Christine
    Montalban, Xavier
    Brassat, David
    Comabella, Manuel
    ANNALS OF NEUROLOGY, 2017, 82 (02) : 186 - 195
  • [7] Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients
    Rossi, Francesca
    Newsome, Scott D.
    Viscidi, Raphael
    MOLECULAR AND CELLULAR PROBES, 2015, 29 (01) : 54 - 62
  • [8] Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients
    Nature Reviews Neurology, 2012, 8 (7) : 358 - 358
  • [9] Progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients in Spain: more than expected?
    Castillo-Trivino, T.
    Arroyo, R.
    De Andres, C.
    Fernandez-Bolanos, R.
    Garcia-Merino, A.
    Landete, L.
    Menendez, M.
    Oliva, P.
    Oterino, A.
    Paramo, M. D.
    Saiz, A.
    Olascoaga, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 370 - 370
  • [10] Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients
    Dalla Costa, Gloria
    Martinelli, Vittorio
    Moiola, Lucia
    Sangalli, Francesca
    Colombo, Bruno
    Finardi, Annamaria
    Cinque, Paola
    Kolb, Eva-Maria
    Haghikia, Aiden
    Gold, Ralf
    Furlan, Roberto
    Comi, Giancarlo
    ANNALS OF NEUROLOGY, 2019, 85 (04) : 606 - 610
12345